Genpact Limited (NYSE:G) will release its earnings data after the market closes on Tuesday, November 7th. Analysts expect Genpact Limited to post earnings of $0.42 per share for the quarter. Genpact Limited has set its FY17 guidance at $1.53-1.57 EPS.

Genpact Limited (NYSE:G) last posted its quarterly earnings data on Wednesday, August 2nd. The business services provider reported $0.41 EPS for the quarter, beating the consensus estimate of $0.31 by $0.10. Genpact Limited had a return on equity of 23.33% and a net margin of 10.22%. The business had revenue of $670.70 million for the quarter, compared to the consensus estimate of $642.68 million. During the same quarter in the prior year, the business earned $0.36 earnings per share. Genpact Limited’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, analysts expect Genpact Limited to post $1.56 EPS for the current fiscal year and $1.75 EPS for the next fiscal year.

Genpact Limited (G) opened at 30.20 on Tuesday. The company has a 50-day moving average price of $29.04 and a 200 day moving average price of $27.78. The stock has a market cap of $5.83 billion, a P/E ratio of 22.81 and a beta of 0.53. Genpact Limited has a 1-year low of $22.62 and a 1-year high of $31.93.

TRADEMARK VIOLATION NOTICE: “Genpact Limited (G) to Release Earnings on Tuesday” was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/10/31/genpact-limited-g-to-release-earnings-on-tuesday.html.

G has been the topic of a number of analyst reports. BMO Capital Markets lifted their target price on shares of Genpact Limited from $26.00 to $30.00 and gave the company a “market perform” rating in a research note on Thursday, August 3rd. Robert W. Baird restated an “outperform” rating and set a $34.00 target price on shares of Genpact Limited in a research note on Wednesday, August 16th. Cowen and Company set a $33.00 target price on shares of Genpact Limited and gave the company a “buy” rating in a research note on Tuesday, August 15th. Deutsche Bank AG lifted their target price on shares of Genpact Limited from $26.00 to $28.00 and gave the company a “hold” rating in a research note on Thursday, August 3rd. Finally, BidaskClub cut shares of Genpact Limited from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 16th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $32.38.

In other Genpact Limited news, insider Mohit Thukral sold 25,000 shares of the business’s stock in a transaction on Friday, August 25th. The shares were sold at an average price of $28.37, for a total value of $709,250.00. Following the sale, the insider now owns 85,305 shares in the company, valued at approximately $2,420,102.85. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Amit Chandra sold 275,508 shares of the business’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $28.72, for a total transaction of $7,912,589.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,379,170 shares of company stock worth $298,097,116. Corporate insiders own 1.41% of the company’s stock.

An institutional investor recently raised its position in Genpact Limited stock. The Manufacturers Life Insurance Company boosted its stake in Genpact Limited (NYSE:G) by 7.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,508 shares of the business services provider’s stock after purchasing an additional 455 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Genpact Limited were worth $181,000 as of its most recent SEC filing. 92.50% of the stock is currently owned by hedge funds and other institutional investors.

Genpact Limited Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Earnings History for Genpact Limited (NYSE:G)

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.